Posts In: Pharma

Mankind Pharma sets a new benchmark launches 120 Premium DMF Quality Drugs for Indian Patients

In its steadfast commitment to enhancing quality healthcare access, Mankind Pharma, a leading pharmaceutical company is proud to unveil a significant stride with the introduction...

Continue Reading

Sun Pharma aims to spend 7-8 pc of sales on R&D this fiscal

Sun Pharmaceutical Industries Ltd aims to spend 7-8 per cent of its sales in the current fiscal on research and development activities as it looks...

Continue Reading

Lupin receives US FDA marketing approval for generic Esbriet capsules

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New...

Continue Reading

Dr. Reddy’s and Sunil Gavaskar collaborate for #TensionMatLo campaign

Dr. Reddy’s Laboratories Limited, a global pharmaceutical company, has announced the appointment of cricket legend Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign.The...

Continue Reading

New scheme for R&D in pharma, medtech

The Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) would have a financial outlay of ₹5,000 crore, over a period of...

Continue Reading

Scientists Develop Drug That Prevents Weight Gain in Junk-Food-Eating Mice

Mice fed a high-sugar, high-fat diet for most of their lives managed to escape weight gain and protect their livers when they were treated with...

Continue Reading

Dr. Reddy’s CDMO subsidiary Aurigene plans $40M expansion in India

Aurigene Pharmaceutical Services, a unit of Indian drugmaker Dr. Reddy’s Laboratories, is planning to spend (PDF) $40 million to build a production facility for therapeutic...

Continue Reading

Glenmark Pharma looking to divest 8 per cent in Glenmark Life Sciences

The management of Glenmark Pharmaceuticals is looking to divest about 8 per cent stake in Glenmark Life Sciences, to align with a regulatory requirement on...

Continue Reading

With FDA approval for Elrexfio, Pfizer brings multiple myeloma battle to Johnson & Johnson

The FDA approved Pfizer’s Elrexfio, or elranatamab, for patients with multiple myeloma who’ve tried at least four prior lines of therapy.Elrexfio will go toe to...

Continue Reading